• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number TBD
Device Problem Degraded (1153)
Patient Problems Aortic Regurgitation (1716); Aortic Valve Stenosis (1717); Cardiac Arrest (1762); Death (1802); Renal Failure (2041)
Event Type  Death  
Manufacturer Narrative
The manufacturer is reporting this event in a conservative manner due to the device malfunction (structural valve deterioration) identified prior to the patient's death.However, at this time there is no further information available on the device functionality over time, treatment provided, and device relationship with the patient's death.Further investigation is ongoing and an update will be provided should further information be received.
 
Event Description
The manufacturer was notified that a patient received a perceval valve in 2012.The patient was admitted with cardiac and renal failure in 2019 and died a week after the admission.Severe aortic stenosis and moderate aortic regurgitation was identified on the last echo prior to the patient's death.
 
Manufacturer Narrative
The manufacturer attempted to retrieve additional information on the event, but no further information has been received to date despite the attempts.As the device was not returned for analysis and the serial number remains unknown, no further investigation is possible at this time.Based on the available information, it is not possible to establish a definitive root cause for the reported event.Structural valve deterioration is included as a possible adverse event in the perceval ifu.Thus, the event is a known inherent risk of the device.Since no further information was provided on the event, patient's clinical history, device functionality over time, the root cause of the event and the relationship between the perceval valve with the patient's death cannot be definitively stated.Should further information be provided in the future, the manufacturer will re-assess the event and provide an update to this reporting activity.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc
MDR Report Key10946809
MDR Text Key219552649
Report Number1718850-2020-01205
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup
Report Date 11/04/2020,01/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/04/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTBD
Device Catalogue NumberTBD
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date12/15/2020
Event Location Hospital
Date Report to Manufacturer11/04/2020
Date Manufacturer Received11/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age86 YR
-
-